ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,371Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 35

$1.26M Total Retail Price of All Prescriptions

Rank: 4 out of 35

716 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 716 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

16% of this provider’s 716 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 16,831 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 33.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
SIMVASTATIN 903 819 1 6
HYDROCODONE-ACETAMINOPHEN 698 518 S3 2 2
LEVOTHYROXINE SODIUM 641 576 3 3
FUROSEMIDE 509 488 4 1
OMEPRAZOLE 502 432 5 4
LISINOPRIL 467 382 6 5
METOPROLOL TARTRATE 441 370 7 11
CRESTOR 400 340 8 71
FAMOTIDINE 367 290 9 35
AMLODIPINE BESYLATE 334 316 10 9
DONEPEZIL HCL 309 301 11 7
WARFARIN SODIUM 305 301 12 8
SERTRALINE HCL 304 300 13 18
GABAPENTIN 293 244 14 14
ATORVASTATIN CALCIUM 292 266 15 28
CARVEDILOL 270 263 16 25
TRAMADOL HCL 269 233 17 24
LOVAZA 248 211 18 123
NAMENDA 239 237 19 12
POTASSIUM CHLORIDE 231 215 20 10
AZITHROMYCIN 229 192 21 57
METFORMIN HCL 225 162 22 19
CITALOPRAM HBR 222 203 23 13
METOPROLOL SUCCINATE 218 182 24 20
HYDROCHLOROTHIAZIDE 216 188 25 22
ESCITALOPRAM OXALATE 210 199 26 30
ALENDRONATE SODIUM 204 202 27 33
TAMSULOSIN HCL 194 160 28 29
LOSARTAN POTASSIUM 186 183 29 38
DIGOXIN 183 178 30 49
MIRTAZAPINE 168 168 31 16
PREDNISONE 166 145 32 36
GLIMEPIRIDE 162 150 33 85
CLOPIDOGREL 156 148 34 34
LOSARTAN-HYDROCHLOROTHIAZIDE 155 134 35 111
METFORMIN HCL ER 147 134 36 99
ATENOLOL 147 126 36 31
ADVAIR DISKUS 146 137 38 46
CEPHALEXIN 138 132 39 50
FLUTICASONE PROPIONATE 132 121 40 62
TRAZODONE HCL 126 114 41 23
CYMBALTA 122 69 42 17
SINGULAIR 121 99 43 113
DIOVAN HCT 114 101 44 192
LIDODERM 111 86 45 55
PANTOPRAZOLE SODIUM 111 105 45 37
DIOVAN 98 94 47 66
CEFUROXIME 97 83 48 77
FENTANYL 95 95 S2 49 52
MONTELUKAST SODIUM 94 68 50 173
ZOLPIDEM TARTRATE 90 70 51 41
PLAVIX 89 84 52 56
KLOR-CON M20 87 75 53 73
MUPIROCIN 86 70 54 176
LANTUS 85 77 55 26
NEXIUM 84 70 56 50
SPIRIVA 82 69 57 61
ALLOPURINOL 81 67 58 47
ZETIA 80 60 59 100
POLYETHYLENE GLYCOL 3350 79 54 60 15
DOXYCYCLINE HYCLATE 77 64 61 66
LEVOFLOXACIN 76 59 62 75
LISINOPRIL-HYDROCHLOROTHIAZIDE 75 59 63 93
NOVOLOG 74 66 64 42
TRIAMTERENE-HCTZ 74 54 64 83
ACTOS 72 65 66 226
SPIRONOLACTONE 71 60 67 54
PRAVASTATIN SODIUM 68 67 68 32
TRIAMCINOLONE ACETONIDE 66 65 69 195
PAROXETINE HCL 65 50 70 88
RAMIPRIL 64 64 71 94
JANUVIA 62 62 72 125
TRILIPIX 62 60 72 224
CILOSTAZOL 62 51 72 229
FENOFIBRATE 62 47 72 132
EXELON 61 61 76 59
AMLODIPINE BESYLATE-BENAZEPRIL 61 54 76 227
TRICOR 58 46 78 190
PROAIR HFA 57 30 79 114
KLOR-CON 10 57 55 79 142
ROPINIROLE HCL 54 40 81 69
LEXAPRO 54 51 81 98
VENLAFAXINE HCL ER 53 29 83 89
VESICARE 52 46 84 128
PROCRIT 50 50 85 321
INSULIN SYRINGE 50 38 85 153
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.